Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
American Journal of Epidemiology|October 16, 2019
Population-Level Sexual Mixing According to HIV Status and Preexposure Prophylaxis Use Among Men Who Have Sex With Men in Montreal, Canada: Implications for HIV PreventionLinwei Wang, Nasheed Moqueet, Gilles Lambert, et al.
Vox Sanguinis|January 25, 2024
End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferralAntoine Lewin, Mindy Goldman, Michael P Busch, et al.
Trials|July 16, 2020
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, CanadaJulie K Wright, Darrell H S Tan, Sharon L Walmsley, et al.
The Lancet. HIV|October 17, 2021
Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR studyChloe Orkin, Enrique Bernal Morell, Darrell H S Tan, et al.
CMAJ Open|May 22, 2021
Use of HIV pre-exposure prophylaxis among urban Canadian gay, bisexual and other men who have sex with men: a cross-sectional analysis of the Engage cohort studyJoseph Cox, Herak Apelian, Erica E M Moodie, et al.
MMWR. Morbidity and Mortality Weekly Report|September 22, 2022
Two Cases of Monkeypox-Associated Encephalomyelitis - Colorado and the District of Columbia, July-August 2022Daniel M Pastula, Matthew J Copeland, Markus C Hannan, et al.
BMJ (Clinical Research Ed.)|March 24, 2022
Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE)Michael Fralick, Michael Colacci, Laveena Munshi, et al.
The Lancet. HIV|April 1, 2021
Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR studyChloe Orkin, Shinichi Oka, Patrick Philibert, et al.
Vaccines|May 25, 2024
Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 StudyCecilia T Costiniuk, Terry Lee, Joel Singer, et al.
AIDS (London, England)|December 8, 2022
COVID-19 vaccine immunogenicity in people with HIVCecilia T Costiniuk, Joel Singer, Terry Lee, et al.
Pageof 15